Xencor, Inc. (XNCR) — Stock Score Summary

Xencor, Inc. (XNCR) has a MoatMap StockRank of 16/100 based on Quality (29/100), Value (41/100), and Momentum (30/100) factor scores. The current signal is STRONG SELL. Xencor is a clinical-stage biopharmaceutical company. Although it has some established partnerships, it remains unprofitable with highly volatile cash flows, failing our Terry Smith quality compounder test.

Xencor, Inc. is a clinical-stage biotechnology company focused on developing engineered monoclonal antibodies for cancer and autoimmune diseases, utilizing its proprietary XmAb® technology platform. This platform provides a significant competitive moat by enabling the creation of antibodies with enhanced therapeutic functions and improved half-life. Xencor operates as a research-intensive biotech, often partnering with larger pharmaceutical companies to develop its innovative pipeline.

Key Financial Metrics

Price$11.89
Market Cap$887M
P/E (Forward)-3.37
Price/Book1.36
Return on Equity-29.8%
Return on Invested Capital-7.4%
Debt/Equity33.97
Gross Margin-152.2%
Operating Margin-1724.1%
Revenue Growth-86.2%
Free Cash Flow$-77M

Xencor, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Xencor, Inc.’s (XNCR) StockRank?
MoatMap’s StockRank for Xencor, Inc. (XNCR) is 16/100, with a Strong Sell signal. It is a composite of Quality (29), Value (41), and Momentum (30) factor ranks across MoatMap’s 19,000+ stock universe.
Does Xencor, Inc. have an economic moat?
Xencor, Inc. (XNCR) has a Quality factor score of 29/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Xencor, Inc. a buy, hold, or sell?
MoatMap’s current signal for Xencor, Inc. (XNCR) is Strong Sell, based on a StockRank of 16/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Xencor, Inc. in?
Xencor, Inc. (XNCR) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksXNCR deep dive reportAI ChampionsHow we score stocksSense-check another stock